NASDAQ NMS - GLOBAL MARKET · ADIL
-4.70% · -$0.1400
Adial Pharmaceuticals Inc

Adial Pharmaceuticals Inc

Pharmaceuticals
$2.84
+ Add to watchlist
Card

Veridion Score

Loading
Score loading…
Veridion Score History · 90D

Composite trend over time

LOADING HISTORY…
REFRESHES DAILY
AI Analysis
Sovereign

Why is ADIL moving today?

Sovereign unlock connects news, insider activity, analyst moves, and live price action.
About Adial Pharmaceuticals Inc
PHARMACEUTICAL PREPARATIONS
Founded
—
Listed
2018
Employees
6
HQ
US

Adial Pharmaceuticals Inc is a clinical-stage biopharmaceutical company focused on the development of therapeutics for the treatment or prevention of addiction and related disorders. Its investigational new drug candidate, AD04, is being developed as a therapeutic agent for the treatment of alcohol use disorder. The company operates as one operating segment with a focus on drug development for addiction and related disorders.

Company website →
Key statistics

Real vendor fields plus Veridion-computed history. Missing fields stay blank.

Open
$2.53
Day high
$3.14
Day low
$2.52
Previous close
$2.98
52W high
$3.50
-18.86% from high
52W low
$2.16
51% of range
Market cap
$6.4M
P/E
—
EPS
—
Dividend yield
—
Beta
—
Shares out
2.1M
Float
—
Volume
853.6K
Avg volume
—
VWAP
$2.79
Next earnings
—
Price history computed in-house
1W
+31.48%
1M
+31.48%
3M
+31.48%
1Y
+31.48%
YTD
+31.48%
SMA 50 $2.83 · above
SMA 200 $2.83 · above
52W position 51%
Veridion warehouse edge

Warehouse intelligence for ADIL.

Veridion Score
59
0: 891: 652: 793: —4: —5: 70
Congress 30d
0
No recent disclosure on file.
Insider activity
See Form 4 panel below.
13F holders
—
Capital Web snapshots checked.
Disclosure-sourced lobbying and contract detail remains attributed in the full panels below.
Data ledger
Quote and day range
Refresh interval: 30 seconds
Source: Market data
Veridion Score
Coverage building
Source: Veridion methodology
Chart and risk context
Daily bars with no missing-bar fill
Source: Market data
News and filings
Refresh intervals shown inside each panel
Source: Market news and federal filings
Financials
Loading quarterly statements…
SEC Form 4 ledger

ADIL insider activity

Adial Pharmaceuticals Inc

Score
Coverage building
Pressure
Mixed
Filings
0
Buys / sells
0 / 0
Net value
$0
Insiders
0
Cluster

No multi-insider buying cluster in the last 90 days

Net pressure

Mixed: $0 across loaded Form 4 rows.

Convergence not established

Loaded official disclosures do not show all three sources aligned on this ticker.

Coverage building

The current Form 4 feed did not return value-bearing open-market rows for ADIL.

Source: SEC EDGAR Form 4. Rows with missing price or quantity are excluded rather than zero-filled.Methodology
Congress · 90D
Loading PTR filings…
Federal contracts

ADIL contract awards, year to date.

Public federal awards linked to this ticker.

—
Refresh interval: 12hSource: Federal contract awards
No federal contracts on file for ADIL in this window.
Lobbying spend

ADIL lobbying filings, year to date.

Registered lobbying filings matched to Adial Pharmaceuticals Inc.

$20.0K
Refresh interval: 12hSource: LDA disclosure filings
Health IssuesHealth Issues Defense
Filing
$10.0K
ADIAL PHARMACEUTICALS INC.

RK STRATEGIES, INC.

Apr 20, 2026
Filing
$10.0K
ADIAL PHARMACEUTICALS INC.

RK STRATEGIES, INC.

Jan 20, 2026
Latest news · ADIL
Refresh interval: 5 minutes · Source: Market news insights
Loading articles…
Analyst ratings
Sovereign unlock shows live analyst consensus for ADIL.
Options
Sovereign unlock shows live options positioning for ADIL.
Weekly Veridion brief

Rating changes, public disclosure activity, methodology notes, and product updates. One email per week. No advertising list resale.